Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs - Summary - MDSpire

Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs

  • By

  • Kerry R. Love

  • Stacy E. Martin

  • Laura Crowell Orella

  • May 18, 2026

  • 0 min

Share

Objective:

Emphasize the critical role of mAbs in improving pediatric health outcomes.

Key Findings:
  • Include specific data or examples to support the effectiveness of mAbs.
Interpretation:

Expand on the implications for health policy and practice.

Limitations:
  • Suggest potential solutions to the identified limitations.
Conclusion:

Reiterate the urgency of improving access to mAbs for pediatric populations.

Original Source(s)

Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs

  • by Kerry R. Love, Stacy E. Martin, Laura Crowell Orella

  • May 18, 2026

Related Content

Hydrocortisone May Lower Severe CAP Mortality

Network meta-analysis suggests hydrocortisone may offer mortality and ventilation benefits, although evidence certainty remained low.

AI Aid Shows Uneven Reporting Gains

Time savings varied by baseline writing time and radiologist in a proof-of-concept study

Rare Ebola Strain Sparks Global Alert

CDC urges travelers returning from Central Africa to monitor for Ebola symptoms for 21 days.